GOVX

#4940
GeoVax Labs, Inc. - Common Stock
2.1 0 USD
-9.09%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
2.07
2.17
Year Range
0.96
4.39
Daily Change
-9.09%
Monthly Change
+107.92%
6 month change
+44.83%
Year Change
+44.83%
Previous Close
2.3 1
Open
2.1 4
Low
2.0 7
High
2.1 7
Volume
62
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 7.29 M
  • Employee 19
  • Founded 1988
  • CEO David A. Dodd
  • Website www.geovax.com
  • Headquarter Delaware, United States
  • FIGI BBG000BGGJD8
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.19
Price to sales ratio
1.65

GeoVax Labs, Inc. - Common Stock

GeoVax is a clinical-stage biotechnology company which develops vaccines. GeoVax's development platform uses Modified Vaccinia Ankara vector technology, with improvements to antigen design and manufacturing capabilities. GeoVax uses recombinant DNA or recombinant viruses to produce virus-like particles in the person being vaccinated.

News